Satellos Bioscience Inc. (MSCLF)
USD 0.48
(-4.42%)
USD 0.48
(-4.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -8.81 Million CAD | -2516.72% |
| 2022 | -336.94 Thousand CAD | -180.98% |
| 2021 | -119.91 Thousand CAD | -149.0% |
| 2020 | -48.16 Thousand CAD | -319.54% |
| 2019 | 21.93 Thousand CAD | 1526.33% |
| 2018 | -1538.00 CAD | 93.45% |
| 2017 | -23.48 Thousand CAD | 14.33% |
| 2016 | -27.41 Thousand CAD | -24.55% |
| 2015 | -22.01 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - CAD | 100.0% |
| 2024 Q2 | -4.87 Million CAD | 0.0% |
| 2023 Q2 | -1277.00 CAD | -23.38% |
| 2023 FY | -8.81 Million CAD | -2516.72% |
| 2023 Q3 | -2000.00 CAD | -56.62% |
| 2023 Q1 | -1035.00 CAD | 91.86% |
| 2023 Q4 | -3585.00 CAD | -79.25% |
| 2022 Q1 | -30.22 Thousand CAD | 57.13% |
| 2022 FY | -336.94 Thousand CAD | -180.98% |
| 2022 Q4 | -12.71 Thousand CAD | 83.29% |
| 2022 Q3 | -76.08 Thousand CAD | -152.63% |
| 2022 Q2 | -30.11 Thousand CAD | 0.36% |
| 2021 Q3 | -33.47 Thousand CAD | -4270.5% |
| 2021 Q1 | -2835.00 CAD | 98.92% |
| 2021 Q2 | -766.00 CAD | 72.98% |
| 2021 FY | -119.91 Thousand CAD | -149.0% |
| 2021 Q4 | -70.51 Thousand CAD | -110.62% |
| 2020 Q4 | -263.53 Thousand CAD | -103.42% |
| 2020 Q3 | -129.55 Thousand CAD | -226.23% |
| 2020 Q2 | -39.71 Thousand CAD | 90.06% |
| 2020 Q1 | -399.58 Thousand CAD | 0.0% |
| 2020 FY | -48.16 Thousand CAD | -319.54% |
| 2019 FY | 21.93 Thousand CAD | 1526.33% |
| 2018 FY | -1538.00 CAD | 93.45% |
| 2017 FY | -23.48 Thousand CAD | 14.33% |
| 2016 FY | -27.41 Thousand CAD | -24.55% |
| 2015 FY | -22.01 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 11.7 Million USD | 175.32% |
| Arch Therapeutics, Inc. | -2439.00 USD | -361400.615% |
| CSL Limited | 7.56 Billion USD | 100.117% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 107.403% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 5093.77% |
| BioStem Technologies, Inc. | 15.42 Million USD | 157.161% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 191.739% |
| Qrons Inc. | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -2659.564% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 65.823% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 12695.714% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -6996.12% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -18170.167% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 6375.445% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 102.153% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 158.784% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 284335.977% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 190.025% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 13514.374% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -25718.448% |
| Mesoblast Limited | -35.16 Million USD | 74.929% |
| Marizyme, Inc. | 457.7 Thousand USD | 2026.363% |
| Genus plc | 178.7 Million USD | 104.934% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 104.006% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 14269.318% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 2249.623% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -80054.545% |
| ContraFect Corporation | -154 Thousand USD | -5625.325% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -17534.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 11586.302% |
| IMV Inc. | -962.29 Thousand USD | -816.244% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -2175.349% |
| MultiCell Technologies, Inc. | 49.32 USD | 17877228.954% |
| ONE Bio Corp. | 20.12 Million USD | 143.81% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 121.897% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 18130.675% |
| Q BioMed Inc. | -8988.00 USD | -97997.463% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 131.205% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -57064.16% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 119.877% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | -672.356% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -177949.273% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -8941.686% |
| GB Sciences, Inc. | -624.00 USD | -1412880.769% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -10148.989% |
| HST Global, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -4238842.308% |
| Enzolytics Inc. | 30.7 Thousand USD | 28812.388% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 1927.611% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.795% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -1613.669% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 1528.123% |
| Zenith Capital Corp. | - USD | Infinity% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -99459.621% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -10415.331% |
| Kadimastem Ltd | -630.13 Thousand USD | -1299.217% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 992.426% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -74399.366% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 5093.77% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 749.674% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -30303.448% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 2059.146% |
| SYBLEU INC | 11.69 Thousand USD | 75484.747% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 291.341% |
| Bioxytran, Inc. | -8285.00 USD | -106321.243% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -2263.807% |
| Neutra Corp. | 14.33 Thousand USD | 61606.802% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -10652.439% |
| PureTech Health plc | -1.6 Million USD | -450.031% |
| Coeptis Therapeutics, Inc. | -1 Million USD | -780.612% |
| IXICO plc | 3.27 Million USD | 369.633% |
| IntelGenx Technologies Corp. | -694 Thousand USD | -1170.461% |
| Gelesis Holdings, Inc. | -1.79 Million USD | -392.295% |
| CSL Limited | 7.7 Billion USD | 100.114% |
| Cellectis S.A. | 18 Thousand USD | 49083.333% |